[1] 孔令彦, 袁梅, 俞同福,等. 肺内原发淋巴瘤CT表现[J]. 南京医科大学学报(自然科学版), 2017,37(3):355-358.
[2] 李海军,彭德昌,龚洪翰等.原发性回盲部淋巴瘤的CT表现[J].实用放射学杂志,2017,33(5):705-707,719.
[3] Toledanomassiah S, Luciani A, Itti E, et al. Whole-body diffusion-weighted imaging in hodgkin lymphoma and diffuse large B-cell lymphoma[J]. Radiographics, 2015, 35(3):140-145.
[4] Albano D, La G L, Grassedonio E, et al. Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma:what radiologists should know[J]. Magnetic Resonance Imaging, 2016, 34(7):922-931.
[5] Paepe K D, Keyzer F D, Wolter P, et al. Whole-body diffusion-weighted imaging for staging lymphoma:are apparent diffusion coefficient derived histogram parameters useful for lesion characterisation?[J]. Cancer Imaging, 2014, 14(1):1-3.
[6] 丁重阳, 刘红宇, 李天女,等. 化疗后PET/CT在弥漫大B细胞淋巴瘤疗效评价中的价值[J]. 中国实验血液学杂志, 2015, 23(4):1013-1016.
[7] Paschalis A, White A, Corser R, et al. Diffuse large B-cell non-Hodgkins lymphoma:R-mini-CHOP or physician's choice dose-adjusted chemotherapy in patients over 80 years old[J]. Hematological Oncology, 2017, 35(2):5-8.
[8] Waisberg J, Adv A, Pas C, et al. Extensive colorectal lymphomatous polyposis complicated by acute intestinal obstruction:a case report[J]. Journal of Medical Case Reports, 2017, 11(1):190.
[9] Hennedige T, Ng D C E, Tao M, et al. Evaluation of whole body diffusionweighted imaging in the staging and treatment response of lymphoma compared with fluoride-oxyglucose (FDG) PET/CT as a reference standard[J]. Open Journal of Radiology, 2017,21(2):17-25.
[10] 陈瑜,郝新宝,苏群豪,等.全身磁共振弥散加权成像和表观弥散系数在恶性淋巴瘤中的应用价值[J].海南医学院学报,2013,19(11):1601-1604.
[11] 刘伯儒. 磁共振全身扩散加权成像在淋巴瘤诊治中的应用价值探讨[J]. 中国肿瘤外科杂志, 2016, 8(3):185-187.
[12] 李莉, 索凌云, 李静,等. 全身扩散加权成像在恶性淋巴结病变中的诊断价值[J]. 磁共振成像, 2015,25(3):213-217.
[13] 李思源. 18F FDG PET/CT对淋巴瘤放化疗后疗效评估及无进展生存期预测的价值[J]. 国际肿瘤学杂志, 2017, 44(5):361-365.
[14] 王攀峰, 李永超, 徐杨,等. 全身弥散加权成像(WB-DWI)在初诊多发性骨髓瘤患者中的诊断和监测作用[J]. 中华血液学杂志, 2017, 38(2):129-133.
[15] 王京. 探讨背景抑制快速全身磁共振弥散成像(WB-DWI)技术在评价恶性肿瘤全身转移的临床应用价值[J]. 世界最新医学信息文摘:电子版, 2016, 16(40):132-133.
[16] 朱振国, 姜熳. 核磁共振全身弥散加权成像(WB-DWI)在乳腺癌患者术前化疗疗效评估中的应用价值[J]. 肿瘤学杂志, 2016, 22(6):443-447.
[17] 张守林, 华小林, 杨传盛,等. MR全身扩散加权成像与核素骨显像对恶性肿瘤骨转移灶检出及疗效比较[J]. 医疗装备, 2016, 29(22):3-4.
[18] 郑进天, 黄波, 莫旭林,等. 核磁共振全身扩散加权成像对多发性骨髓瘤的诊断价值[J]. 中国癌症防治杂志, 2016, 8(3):174-176. |